FDA gives Sorin nod on trial for sutureless aortic valve

05/2/2013 | Clinica (subscription required)

The FDA has given Sorin the OK to start a clinical study of its Perceval S sutureless aortic tissue valve, moving the Italian cardiovascular firm closer to obtaining premarket approval for the product. The trial will involve aortic stenosis patients from as many as 25 clinical sites in the U.S.

View Full Article in:

Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID